Recent work has identified two proteins that work together to enable many c
ell types to respond to endotoxin. These two proteins, lipopolysaccharide (
LPS) binding protein (LBP) and CD14, also participate in cellular internali
zation of endotoxin, which may occur independently of cellular activation.
Current work with antibodies to LBP and CD14 as well as "knockout" mice in
the context of LPS-initiated endotoxic shock suggests that inhibition of th
is pathway could be therapeutically useful. These observations point to the
need to identify new molecules that mediate LPS-initiated transmembrane si
gnaling and internalization of LPS-protein complexes.